Center for Research in Emerging Infectious Diseases in East and Central Africa Plus
Official title: CENTER FOR RESEARCH IN EMERGING INFECTIOUS DISEASES- EAST AND CENTRAL AFRICA PLUS
Funded at Washington State University · NIH-11601584 · Data updated 2026-11-12
A national/international research center works to understand and respond to emerging infectious diseases in East and Central Africa, with implications for global health.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington State University NIH-funded |
| Lab location | 1 site (Pullman, United States) |
| Project start | June 1, 2020 |
| Project end | June 30, 2031 |
| Funding year | 2026 |
| Award (this year) | $136,200 |
| NIH project number | 3U01AI151799-06S1 |
| Project ID | NIH-11601584 on NIH RePORTER |
Who could benefit from this research
✓Could help
Researchers and public health teams in the East and Central Africa region that collaborate on outbreak response and disease characterization.
✕Less likely to help
Direct patient benefits may be limited to communities, health systems, and professionals involved in outbreak response; individual patients may not be participants in this grant.
What this research studies
This center builds on prior work to study emerging infections that cause disease in people and animals. It conducts outbreak-response research, basic science on viruses, and socio-cultural studies to improve prevention and control. The project involves collaborations across regions, mentorship of trainees, and training of PhD students to sustain expertise. Results are intended to inform public health decisions and outbreak preparedness for communities in East and Central Africa and beyond.
Why it matters
Potential benefit: If successful, the program could improve outbreak response, disease understanding, and prevention strategies that protect communities in East and Central Africa and neighboring regions.
How similar studies have gone: Previous rounds produced numerous manuscripts and grant successes, indicating a productive and impactful research approach.
Where this research is happening
-
Washington State University
Pullman, United States Active
Researchers
- Principal investigator: Njenga, M Kariuki — Washington State University
- Study coordinator: Njenga, M Kariuki
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.